Chunmei Xiao Fangye Xu Rong Wang Qi Liang Kai Shen Jiali Xu Lianke Liu
10.2147/OTT.S335139
Onco Targets Ther
2021 Dec 1;14:5363-5372.
antiangiogenic therapy apatinib endostar gefitinib ovarian cancer
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/34880628/
Case Reports
PMC8646866
34880628
Endostar Plus Apatinib Successfully Achieved Long Term Progression-Free Survival in Refractory Ovarian Cancer: A Case Report and Literature Review
2021